Screening program collaborations
Fast MDx welcomes collaboration with academics, charities and funders to develop early-detection screening programs.
Source: LinkedIn company description · Retrieved October 13, 2026
Fast MDx is a social enterprise aiming to democratise molecular diagnostics.
Fast MDx offers the NGX 124 molecular diagnostics platform for extracted nucleic acid or direct qPCR assays. Fast MDx is developing AI tools for early detection of infection hotspots.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Fast MDx welcomes collaboration with academics, charities and funders to develop early-detection screening programs.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026, October 8, 2026 and October 9, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.